Lu Xu

1.4k total citations · 1 hit paper
47 papers, 1.1k citations indexed

About

Lu Xu is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lu Xu has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Lu Xu's work include Liver Disease Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Lu Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Lu Xu collaborates with scholars based in China, United States and Hong Kong. Lu Xu's co-authors include Rong Qi, Cong Chen, Wuyuan Zhou, Jiawei Xie, Guomin Hu, Xuesong Liu, Qinyu Wang, Hui Dai, Youyi Zhang and Han Xiao and has published in prestigious journals such as FEBS Letters, British Journal of Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Lu Xu

44 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice

2019 230 citations Lu Xu, Rong Qi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu Xu China	18	439	316	314	221	164	47	1.1k
Barbara Vizio Italy	19	369 0.8×	327 1.0×	238 0.8×	209 0.9×	143 0.9×	34	1.1k
Shufei Zang China	18	331 0.8×	529 1.7×	122 0.4×	161 0.7×	177 1.1×	46	1.1k
Kaili Fu China	12	573 1.3×	461 1.5×	181 0.6×	85 0.4×	138 0.8×	14	1.1k
Peixin Huang China	14	266 0.6×	131 0.4×	241 0.8×	123 0.6×	147 0.9×	45	868
Xin Dong China	21	549 1.3×	187 0.6×	365 1.2×	88 0.4×	176 1.1×	68	1.3k
Romi Ghose United States	19	444 1.0×	137 0.4×	397 1.3×	138 0.6×	55 0.3×	45	1.1k
Qinghui Zhang China	21	635 1.4×	325 1.0×	188 0.6×	122 0.6×	479 2.9×	42	1.3k
Martin Leníček Czechia	20	490 1.1×	366 1.2×	265 0.8×	80 0.4×	113 0.7×	65	1.2k
Yutong Wang China	18	526 1.2×	169 0.5×	311 1.0×	123 0.6×	178 1.1×	99	1.3k

Countries citing papers authored by Lu Xu

Since Specialization

Citations

This map shows the geographic impact of Lu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Xu more than expected).

Fields of papers citing papers by Lu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Xu. The network helps show where Lu Xu may publish in the future.

Co-authorship network of co-authors of Lu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Xu. A scholar is included among the top collaborators of Lu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Xu. Lu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Yaoyao, Shihao Liu, Lisha Yu, et al.. (2025). Geraniin Alleviates High‐Fat Diet‐Induced Atherosclerosis in ApoE ^−/− Mice. Food Science & Nutrition. 13(7). e70693–e70693.

Li, Ling, et al.. (2025). Apoptotic vesicles of mesenchymal stem cells promote M2 polarization and alleviate early-onset preeclampsia via miR-191-5p. Stem Cell Research & Therapy. 16(1). 414–414. 1 indexed citations

Jiang, Tiejia, et al.. (2024). Efficacy of propofol and midazolam combination in managing refractory epileptic encephalopathy with spike-wave activation in sleep. Epilepsy & Behavior Reports. 29. 100732–100732.

Yang, Xin, et al.. (2023). Clinicopathological features and prognosis of patients with HER2-low breast cancer. BMC Cancer. 23(1). 914–914. 4 indexed citations

Li, Deqiang, et al.. (2023). JMJD6–BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells. Journal of Translational Medicine. 21(1). 752–752. 15 indexed citations

Li, Deqiang, et al.. (2023). LOXL4 Shuttled by Tumor Cells–derived Extracellular Vesicles Promotes Immune Escape in Hepatocellular Carcinoma by Activating the STAT1/PD-L1 Axis. Journal of Immunotherapy. 47(2). 64–76. 8 indexed citations

Li, Deqiang, et al.. (2023). Extracellular Vesicle-Loaded Oncogenic lncRNA NEAT1 from Adipose-Derived Mesenchymal Stem Cells Confers Gemcitabine Resistance in Pancreatic Cancer via miR-491-5p/Snail/SOCS3 Axis. Stem Cells International. 2023. 1–21. 14 indexed citations

Xu, Lu, et al.. (2022). Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma. Digestive and Liver Disease. 55(3). 412–421. 4 indexed citations

Xu, Lu, et al.. (2022). Oenothein B ameliorates hepatic injury in alcoholic liver disease mice by improving oxidative stress and inflammation and modulating the gut microbiota. Frontiers in Nutrition. 9. 1053718–1053718. 18 indexed citations

10.

Xu, Lu, et al.. (2022). Suppression of histone deacetylase 1 by JSL-1 attenuates the progression and metastasis of cholangiocarcinoma via the TPX2/Snail axis. Cell Death and Disease. 13(4). 324–324. 9 indexed citations

11.

Xu, Lu, Jing Shi, Lei Zhao, et al.. (2020). Prognostic Value and Influence of Receptor Conversion on Treatment Regimen in Metastatic Breast Cancer at the First Time of Recurrence. Oncology Research and Treatment. 43(11). 620–627. 6 indexed citations

12.

Sun, Yixin, Hui Li, Zhengcun Pei, et al.. (2020). Incidence of community-acquired pneumonia in urban China: A national population-based study. Vaccine. 38(52). 8362–8370. 77 indexed citations

13.

Xie, Jiarong, Lu Xu, Peifei Li, et al.. (2019). Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis. BMC Gastroenterology. 19(1). 87–87. 20 indexed citations

14.

Xu, Lu, et al.. (2019). Megacolon as the presenting feature of multiple endocrine neoplasia type 2B: a case report. Hong Kong Medical Journal. 25(6). 483–486. 2 indexed citations

15.

Li, Peifei, et al.. (2018). IDDF2018-ABS-0074 CIRCSCD1 promotes fatty liver disease via the janus kinase 2/signal transducer and activator of transcription 5 pathway. A22.2–A22. 2 indexed citations

16.

Li, Wěi, Ling Xu, Xiaofang Che, et al.. (2018). C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells. BMC Cancer. 18(1). 507–507. 10 indexed citations

17.

Zeng, Xue, Xiaofang Che, Yunpeng Liu, et al.. (2017). FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2-positive breast cancer cells. Experimental and Therapeutic Medicine. 14(4). 3265–3272. 10 indexed citations

18.

Cao, Yini, Lu Xu, Cong Chen, et al.. (2016). Fenofibrate nanoliposome: Preparation and its inhibitory effects on nonalcoholic fatty liver disease in mice. Nanomedicine Nanotechnology Biology and Medicine. 12(8). 2449–2458. 14 indexed citations

19.

Qi, Rong, Lu Xu, Wenwen Shen, et al.. (2015). G5 PAMAM dendrimer versus liposome: A comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin. Nanomedicine Nanotechnology Biology and Medicine. 11(5). 1141–1151. 33 indexed citations

20.

Wang, Min, Lu Xu, Mingzhang Gao, et al.. (2012). Synthesis of 2-[11C]methoxy-3,17β-O,O-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers. Steroids. 77(8-9). 864–870. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact